4.5 Article

Structural and sequence variants in patients with Silver-Russell syndrome or similar features-Curation of a disease database

Journal

HUMAN MUTATION
Volume 39, Issue 3, Pages 345-364

Publisher

WILEY
DOI: 10.1002/humu.23382

Keywords

11p15; growth retardation; LOVD database; methylation; NH-CSS; sequence variant; Silver-Russell syndrome; SRS; structural variant

Funding

  1. COST(Cost Action) [BM1208]
  2. Bundesministerium fur Bildung und Forschung (Network Imprinting Diseases) [01GM1513B]
  3. Deutsche Forschungsgemeinschaft (DFG) [EG110/15-1]
  4. Universite Pierre et Marie Curie
  5. Association Francaises des Familles ayant un enfant atteint du Syndrome Silver Russell ou ne Petit pour l'Age Gestationnel (AFIF/PAG)

Ask authors/readers for more resources

Silver-Russell syndrome (SRS) is a clinically and molecularly heterogeneous disorder involving prenatal and postnatal growth retardation, and the term SRS-like is broadly used to describe individuals with clinical features resembling SRS. The main molecular subgroups are loss of methylation of the distal imprinting control region (H19/IGF2:IG-DMR) on 11p15.5 (50%) and maternal uniparental disomy of chromosome 7 (5%-10%). Through a comprehensive literature search, we identified 91 patients/families with various structural and small sequence variants, which were suggested as additional molecular defects leading to SRS/SRS-like phenotypes. However, the molecular and phenotypic data of these patients were not standardized and therefore not comparable, rendering difficulties in phenotype-genotype comparisons. To overcome this challenge, we curated a disease database including (epi) genetic phenotypic data of these patients. The clinical features are scored according to the Netchine-Harbison clinical scoring system (NH-CSS), which has recently been accepted as standard by consensus. The structural and sequence variations are reviewed and where necessary redescribed according to recent recommendations. Our study provides a framework for both research and diagnostic purposes through facilitating a standardized comparison of (epi) genotypes with phenotypes of patients with structural/sequence variants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available